The U.S. Food and Drug Administration (FDA) cleared Dutch medtech company Nico.Lab's StrokeViewer LVO, an artificial intelligence (AI) algorithm that detects image characteristics associated with a large vessel occlusion (LVO).
The cloud-based software sends a notification to the medical specialists involved with the stroke case minutes after a patient arrives in the hospital. Physicians are able to use their smartphones both in the hospital and at home to inspect the CT images in a web viewer and diagnose a stroke.
This is the firm's first FDA clearance, but StrokeViewer is currently in use in Australia and Europe.
